Your browser doesn't support javascript.
Smell and taste of milk during tube feeding of preterm infants: neurodevelopmental follow-up of the randomized TASTE trial, study protocol.
Beker, Friederike; Hughes, Ian P; Jacobs, Sue; Liley, Helen G; Bora, Samudragupta; Simcock, Gabrielle; Davis, Peter G.
  • Beker F; Mater Research Institute, Faculty of Medicine, The University of Queensland, South Brisbane, Queensland, Australia. friederike.beker@mater.org.au.
  • Hughes IP; Neonatal Critical Care Unit, Mater Mothers' Hospitals, South Brisbane, Queensland, Australia. friederike.beker@mater.org.au.
  • Jacobs S; Office of Research Governance and Development, Gold Coast University Hospital, Southport, Queensland, Australia.
  • Liley HG; Neonatal Services and Newborn Research, The Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Bora S; Clinical Sciences Research, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Simcock G; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.
  • Davis PG; Mater Research Institute, Faculty of Medicine, The University of Queensland, South Brisbane, Queensland, Australia.
Trials ; 24(1): 290, 2023 Apr 22.
Article in English | MEDLINE | ID: covidwho-2292089
ABSTRACT

BACKGROUND:

The Taste And Smell To Enhance nutrition (TASTE) trial investigated the effects of smell and taste of milk with tube feeding compared to routine care on the growth of preterm infants. There was no difference between groups in growth (weight, head circumference, length) z-scores at discharge from the hospital. Infants in the intervention group had higher head circumference and length z-scores at 36 weeks postmenstrual age, both secondary outcomes. The objective of this follow-up study is to assess 2-year neurodevelopmental and growth outcomes after exposure of preterm infants to the smell and taste of milk with tube feeding compared to routine care.

METHODS:

This is a neurodevelopmental follow-up study of a two-center, placebo-controlled randomized trial. Infants born before 29 weeks postmenstrual age and/or with a birth weight of less than 1250 g were randomized to smell and taste of milk with each tube feed or routine care. The current follow-up assessed the 2-year neurodevelopmental and growth outcomes of participants of the TASTE trial discharged from the hospital (n = 334). The primary outcome is survival free of any major neurodevelopmental impairment comprising any moderate/severe cerebral palsy (Gross Motor Function Classification System score II-V), Bayley Scales of Infant and Toddler Development, Third/Fourth Edition (Bayley-III/Bayley-4) motor, cognitive, or language scores < -2SD, blindness, or deafness at 2 years of age. Other outcomes include death, breastfeeding within the first year, and respiratory support, oral feeding, and anthropometric parameters at 2 years of age. The Human Research Ethics Committees of Mater Misericordiae Limited and the Royal Women's Hospital approved the TASTE trial including the neurodevelopmental follow-up described in this protocol.

DISCUSSION:

For patients and their families, the neurodevelopmental outcomes of preterm infants are of utmost importance. Consequently, they should be investigated following any interventional study performed during the newborn period. Furthermore, improved weight gain and head growth in the hospital are associated with better long-term neurodevelopmental outcomes. Smelling and tasting of milk is an uncomplicated and cost-effective intervention that may improve the growth and neurodevelopmental outcomes of preterm infants. Potential limitations affecting this follow-up study, caused by the COVID-19 pandemic, are anticipated and discussed in this protocol. TRIAL REGISTRATION Name of the registry Australian and New Zealand Clinical Trials Registry; Registration number ACTRN12617000583347 ; Registration date 26 April 2017.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Infant, Premature / COVID-19 Type of study: Cohort study / Experimental Studies / Prognostic study / Randomized controlled trials Limits: Female / Humans / Infant / Infant, Newborn Country/Region as subject: Oceania Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2023 Document Type: Article Affiliation country: S13063-023-07224-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Infant, Premature / COVID-19 Type of study: Cohort study / Experimental Studies / Prognostic study / Randomized controlled trials Limits: Female / Humans / Infant / Infant, Newborn Country/Region as subject: Oceania Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2023 Document Type: Article Affiliation country: S13063-023-07224-0